18-AUG-2026 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S2114-NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 Y 0 CD19 CAR T-cell Therapy 396 241 91 50 21 4 0 06/12/2023 134 44
            241 91 50 21 4 0      
 
    2 Y 1 Mosunetuzumab   13 5 4 2 0 0 06/12/2023    
        2 Polatuzumab   12 4 1 1 0 0      
        3 Mosunetuzumab + Polatuzumab   13 5 3 2 0 0      
        4 Observation   14 6 4 3 1 0      
            52 20 12 8 1 0      
 
    3 Y 5 Mosunetuzumab + Polatuzumab   4 1 0 0 0 0 06/12/2023    
            4 1 0 0 0 0      
 
  S2207-LBCL, Transplant Inelig, Targeted Tx + Tafa 1 Y 1 Tazemetostat (Arm 1) Dose Level 1 173 7 0 0 0 0 0 09/26/2023 141 40
        10 Tazemetostat (Arm 1) Dose Level 1   6 6 0 0 0 0      
        11 Tazemetostat (Arm 1) Dose Level 2   5 5 1 0 0 0      
        13 Zanubrutinib (Arm 3) Dose Level 2   1 1 0 0 0 0      
        4 Zanubrutinib (Arm 3) Dose Level 1   10 0 0 0 0 0      
        5 Zanubrutinib (Arm 3) Dose Level 2   10 0 0 0 0 0      
        9 Tafasitamab + Lenalidomide + Zanubrutinib   1 1 1 1 1 1      
            40 13 2 1 1 1      
 
  S2308-FL, LTB, Mosunetuzumab vs Rituximab 1 Y 1 Rituximab 600 200 124 72 31 9 1 10/23/2024 259 91
        2 Mosunetuzumab   200 123 72 34 8 1      
            400 247 144 65 17 2      
 
Yes A051902-PTCL,CHO(E)PvCC-486-CHO(E)PvDuvelisib-CHO(E)P 1 E Total Registrations   19 0 0 0 0 0 10/14/2023 223 80
            19 0 0 0 0 0      
 
  A052101-Lymph, Stg I-IV, Cont v Intermittent Zanub 1 E Total Registrations   36 16 7 2 1 0 01/03/2024 237 78
            36 16 7 2 1 0      
 
    2 E Total Registrations   16 5 2 2 0 0 01/03/2024    
            16 5 2 2 0 0      
 
  AHOD2131-cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 1 E Total Registrations   113 48 24 13 3 1 08/15/2023 367 133
            113 48 24 13 3 1      
 
    2 E Total Registrations   101 46 24 15 5 2 08/15/2023    
            101 46 24 15 5 2      
 
No A042302-CLL/SLL, Untreated Older, Zan+Son 0 E Total Registrations   11 11 11 11 6 1 06/22/2026 18 5
            11 11 11 11 6 1      
 
    1 E Total Registrations   10 10 10 10 7 2 06/22/2026    
            10 10 10 10 7 2      
 
  EA4231-Lymph, DL B-Cell, Ven+Ib+Pred+Ob+Rev 1 E Total Registrations   1 1 1 0 0 0 03/30/2026 35 9
            1 1 1 0 0 0      
 
  EA4232-Lymph, Peri T Cell, Auto Stem 1 E Total Registrations   2 2 0 0 0 0 09/15/2025 134 38
            2 2 0 0 0 0      
 

18-AUG-2026 6:10

LYMPH Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs		 # of
CURR
IRBs
A042302 CLL/SLL, Untreated Older, Zan+Son 2 Randomization 06-Mar-26 18 5